tirzepatide news september 27 2025 US pharmaceutical giant Eli Lilly's weight loss drug Mounjaro (tirzepatide) records Rs 80 crore in revenue in September, making it the second-most sold drug by value in India. The top-selling drug for A network meta-analysis backed weight-loss

For people with normal kidney function who maintain adequate hydrationcritical when taking semaglutidethe risk profile remains low

People are all very different, and for some women, GLP-1 medications may help them lose a significant amount of weight, which several medical reviews have reported can improve insulin resistance and can gradually normalize menstrual cycles, as well as improve symptoms associated with womens reproductive conditions like PCOS and enhance fertility

Most patients begin regaining weight within 12 weeks of stopping treatment, as appetite hormones rebound rapidly

Many guests report feeling benefits within hours to a day, depending on the injection and their bodys nutrient levels

This personalization can improve outcomes by focusing on what works best for the patient